Hurley Capital’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$593K Buy
24,492
+741
+3% +$17.9K 0.31% 55
2026
Q1
$576K Buy
23,751
+54
+0.2% +$1.31K 0.31% 55
2025
Q4
$575K Buy
23,697
+173
+0.7% +$4.2K 0.32% 55
2025
Q3
$573K Buy
23,524
+6,536
+38% +$159K 0.32% 61
2025
Q2
$412K Buy
16,988
+3,504
+26% +$84.5K 0.29% 59
2025
Q1
$326K Buy
13,484
+2
+0% +$48 0.25% 65
2024
Q4
$323K Buy
+13,482
New +$325K 0.26% 56

Other funds holding IBDS

Hurley Capital's IBDS Position: Q2 2026 in Review

Hurley Capital increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 3.1% in Q2 2026, buying an estimated $17.9K and bringing the position to 24,492 shares worth $593K. The position accounts for 0.31% of the portfolio, ranked #55.

Hurley Capital first reported a position in IBDS in Q4 2024 and has held it in 7 quarters since. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Hurley Capital held 24,492 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $593K as of Q2 2026.
  • Hurley Capital bought 741 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $17.9K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.31% of Hurley Capital's portfolio in Q2 2026, its #55 holding.
  • Hurley Capital first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.